{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:33:05Z","timestamp":1791513185464,"version":"4.3.4"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260933-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Evidence on the safety of atrial fibrillation ablation during rapid growth in both procedural volume and the number of hospitals performing it remains inconsistent. Although clinical registries and randomized trial meta-analyses report extremely low mortality, administrative databases have suggested rates up to 10-fold higher, with concerning temporal increases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260933-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To define the periprocedural mortality risk following elective atrial fibrillation ablation using a validated nationwide database and to determine whether this expansion was associated with diffusion-related safety penalties (ie, transient erosion of safety driven by a widening efficacy-effectiveness gap).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260933-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective, nationwide, population-based cohort study used data from a nationwide administrative database of participating cardiovascular hospitals in Japan from April 1, 2012, to March 31, 2023. Analyses were conducted in 2025 to 2026, with follow-up through discharge from the index hospitalization for the primary outcome. Patients with atrial fibrillation who underwent scheduled elective catheter ablation with transseptal puncture were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260933-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Elective atrial fibrillation ablation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260933-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was in-hospital mortality during the index hospitalization. In-hospital mortality and other event rates are presented as proportions with exact (Clopper-Pearson) binomial 95% CIs. Multivariable analyses used Firth penalized logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260933-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 618\u202f024 catheter ablation procedures, 412\u202f947 were elective atrial fibrillation ablations (median [IQR] patient age, 68 [60-74] years; 288\u202f825 male patients [69.9%]) performed between 2012 and 2022. Annual procedural volume increased from 10\u202f969 procedures in 2012 to 63\u202f014 procedures in 2022. In-hospital mortality occurred in 119 patients (0.029%; 95% CI, 0.024%-0.034%), with a modest but statistically significant decline (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend\u2009=\u2009.04). Within 30 days of the procedure, deaths occurred during the index hospitalization in 91 patients (0.022%; 95% CI, 0.018%-0.027%) and during readmission in 72 patients (0.017%; 95% CI, 0.014%-0.022%). The most frequent concurrent complication among index-hospitalization deaths was cardiac tamponade (26 patients [21.8%]). In Firth penalized multivariable analysis, factors independently associated with in-hospital mortality included older age (odds ratio [OR], 1.04; 95% CI, 1.01-1.07), lower body mass index (OR, 0.94; 95% CI, 0.89-1.00), Charlson Comorbidity Index score of 3 or higher (OR, 4.59; 95% CI, 2.59-8.12), low institutional volume (OR, 2.52; 95% CI, 1.45-4.38), and preserved functional status (Barthel Index &amp;amp;gt;90; OR, 0.11; 95% CI, 0.07-0.19).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260933-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this Japanese nationwide registry study of 412\u202f947 elective atrial fibrillation ablation procedures, in-hospital mortality was 0.029%, comparable to contemporary registry benchmarks. No evidence of a diffusion-related safety penalty was observed during rapid expansion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.34516","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:30:15Z","timestamp":1787995815000},"page":"e2634516","source":"Crossref","is-referenced-by-count":1,"title":["Periprocedural Mortality Risk After Elective Atrial Fibrillation Ablation in Japan"],"prefix":"10.1001","volume":"9","author":[{"given":"Koichi","family":"Inoue","sequence":"first","affiliation":[{"name":"Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshiro","family":"Kanaoka","sequence":"additional","affiliation":[{"name":"Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Ueda","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Abe","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyasu","family":"Ikeoka","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Mishima","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhisa","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Osaki","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Sumita","sequence":"additional","affiliation":[{"name":"Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Iwanaga","sequence":"additional","affiliation":[{"name":"Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan"},{"name":"Cardiovascular Center, Sakurabashi Watanabe Advanced Healthcare Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"issue":"13","key":"zoi260933r1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial.","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"issue":"13","key":"zoi260933r2","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial.","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"issue":"36","key":"zoi260933r3","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"19","key":"zoi260933r4","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.jacc.2009.02.022","article-title":"Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation.","volume":"53","author":"Cappato","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"zoi260933r5","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.113.003862","article-title":"In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures.","volume":"128","author":"Deshmukh","year":"2013","journal-title":"Circulation"},{"issue":"18","key":"zoi260933r6","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.jacc.2019.08.1036","article-title":"Risk of mortality following catheter ablation of atrial fibrillation.","volume":"74","author":"Cheng","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"zoi260933r7","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.cjca.2022.05.024","article-title":"Low 30-day mortality after atrial fibrillation ablation: results from the Netherlands heart registration.","volume":"38","author":"Mol","year":"2022","journal-title":"Can J Cardiol"},{"issue":"5","key":"zoi260933r8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.011365","article-title":"Causes of early mortality after catheter ablation of atrial fibrillation.","volume":"16","author":"Tan","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"zoi260933r9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jacc.2022.11.060","article-title":"Initial findings from the national cardiovascular data registry of atrial fibrillation ablation procedures.","volume":"81","author":"Hsu","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"zoi260933r10","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.jacc.2023.03.418","article-title":"Procedure-related complications of catheter ablation for atrial fibrillation.","volume":"81","author":"Benali","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"zoi260933r11","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1253\/circj.CJ-24-0704","article-title":"Hospitalized patients, treatments, and quality of care for cardiovascular diseases in Japan\u2014outline of the nationwide JROAD Investigation.","volume":"89","author":"Nishi","year":"2025","journal-title":"Circ J"},{"issue":"1","key":"zoi260933r12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1253\/circrep.CR-25-0217","article-title":"Design and framework of JROAD-DPC\u2014a Japanese nationwide registry linking diagnosis procedure combination data with cardiovascular quality metrics.","volume":"8","author":"Shibata","year":"2025","journal-title":"Circ Rep"},{"issue":"10","key":"zoi260933r13","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/CIRCULATIONAHA.118.035858","article-title":"Current status of cardiovascular medicine in the aging society of Japan.","volume":"138","author":"Yasuda","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"zoi260933r14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2188\/jea.JE20200288","article-title":"History and profile of diagnosis procedure combination (DPC): development of a real data collection system for acute inpatient care in Japan.","volume":"31","author":"Hayashida","year":"2021","journal-title":"J Epidemiol"},{"key":"zoi260933r15","first-page":"61","article-title":"Functional evaluation: the Barthel Index.","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"issue":"5","key":"zoi260933r16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"3","key":"zoi260933r17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2307\/3001775","article-title":"Tests for linear trends in proportions and frequencies.","volume":"11","author":"Armitage","year":"1955","journal-title":"Biometrics"},{"issue":"1","key":"zoi260933r18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/jama.2011.916","article-title":"Appropriateness of percutaneous coronary intervention.","volume":"306","author":"Chan","year":"2011","journal-title":"JAMA"},{"issue":"16","key":"zoi260933r19","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1001\/jama.292.16.1961","article-title":"Outcomes of percutaneous coronary interventions performed at centers without and with onsite coronary artery bypass graft surgery.","volume":"292","author":"Wennberg","year":"2004","journal-title":"JAMA"},{"issue":"16","key":"zoi260933r20","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/CIRCULATIONAHA.114.009281","article-title":"Impact of annual operator and institutional volume on percutaneous coronary intervention outcomes: a 5-year United States experience (2005-2009).","volume":"130","author":"Badheka","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"zoi260933r21","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jacc.2016.11.033","article-title":"2016 annual report of the Society of Thoracic Surgeons\/American College of Cardiology transcatheter valve therapy registry.","volume":"69","author":"Grover","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"zoi260933r22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/ejcts\/ezu290","article-title":"The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease.","volume":"46","author":"Mohr","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"zoi260933r23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ejvs.2016.12.019","article-title":"Carotid stenting prior to coronary bypass surgery: an updated systematic review and meta-analysis.","volume":"53","author":"Paraskevas","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"zoi260933r24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2010.1915","article-title":"Non-evidence-based ICD implantations in the United States.","volume":"305","author":"Al-Khatib","year":"2011","journal-title":"JAMA"},{"issue":"17","key":"zoi260933r25","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","article-title":"Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation.","volume":"376","author":"Calkins","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi260933r26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/europace\/euy266","article-title":"Updated systematic review and meta-analysis of the impact of contact force sensing on the safety and efficacy of atrial fibrillation ablation: discrepancy between observational studies and randomized control trial data.","volume":"21","author":"Virk","year":"2019","journal-title":"Europace"},{"issue":"3","key":"zoi260933r27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/europace\/euw262","article-title":"Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: an updated meta-analysis of randomized and observational studies.","volume":"19","author":"Buiatti","year":"2017","journal-title":"Europace"},{"issue":"21","key":"zoi260933r28","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.117.031343","article-title":"Use of intracardiac echocardiography in interventional cardiology: working with the anatomy rather than fighting it.","volume":"137","author":"Enriquez","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"zoi260933r30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/joa3.12081","article-title":"Influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications: analysis of 10 795 procedures in J-CARAF Study 2011-2016.","volume":"34","author":"Murakawa","year":"2018","journal-title":"J Arrhythm"},{"issue":"2","key":"zoi260933r31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/joa3.12163","article-title":"Study design of nationwide Japanese Catheter Ablation Registry: protocol for a prospective, multicenter, open registry.","volume":"35","author":"Yamane","year":"2019","journal-title":"J Arrhythm"},{"issue":"4","key":"zoi260933r32","doi-asserted-by":"publisher","DOI":"10.1002\/joa3.70173","article-title":"The Japanese Catheter Ablation Registry (J-AB): annual report in 2023.","volume":"41","author":"Kusano","year":"2025","journal-title":"J Arrhythm"},{"issue":"3","key":"zoi260933r33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jclinepi.2013.08.015","article-title":"Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects.","volume":"67","author":"McCambridge","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"zoi260933r29","unstructured":"Ministry of Health Labour and Welfare. Abridged life tables for Japan, 2024. December 9, 2025. Accessed August 3, 2026. https:\/www.lifetable.de\/File\/GetDocument\/data\/JPN\/JPN000020242024CU1.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2853284\/inoue_2026_oi_260933_1791207957.84238.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:00:38Z","timestamp":1791471638000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2853284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.34516","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]}}}